Deutsche Bank’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.22M | Sell |
50,915
-3,092
| -6% | -$135K | ﹤0.01% | 1630 |
|
|
2025
Q1 | $1.48M | Sell |
54,007
-18,435
| -25% | -$505K | ﹤0.01% | 1926 |
|
|
2024
Q4 | $2.91M | Buy |
72,442
+28,726
| +66% | +$1.16M | ﹤0.01% | 1606 |
|
|
2024
Q3 | $2.07M | Buy |
43,716
+7,483
| +21% | +$354K | ﹤0.01% | 1692 |
|
|
2024
Q2 | $1.08M | Sell |
36,233
-5,643
| -13% | -$168K | ﹤0.01% | 1923 |
|
|
2024
Q1 | $1.68M | Buy |
41,876
+21,808
| +109% | +$877K | ﹤0.01% | 1726 |
|
|
2023
Q4 | $511K | Buy |
20,068
+184
| +0.9% | +$4.69K | ﹤0.01% | 2334 |
|
|
2023
Q3 | $276K | Buy |
19,884
+2,390
| +14% | +$33.2K | ﹤0.01% | 2543 |
|
|
2023
Q2 | $402K | Sell |
17,494
-7,707
| -31% | -$177K | ﹤0.01% | 2473 |
|
|
2023
Q1 | $747K | Buy |
25,201
+4,220
| +20% | +$125K | ﹤0.01% | 2271 |
|
|
2022
Q4 | $524K | Buy |
20,981
+5,005
| +31% | +$125K | ﹤0.01% | 2419 |
|
|
2022
Q3 | $348K | Sell |
15,976
-4,200
| -21% | -$91.5K | ﹤0.01% | 2594 |
|
|
2022
Q2 | $397K | Sell |
20,176
-13,190
| -40% | -$260K | ﹤0.01% | 2732 |
|
|
2022
Q1 | $1.41M | Sell |
33,366
-2,084
| -6% | -$88.2K | ﹤0.01% | 2108 |
|
|
2021
Q4 | $2.25M | Sell |
35,450
-169
| -0.5% | -$10.7K | ﹤0.01% | 1913 |
|
|
2021
Q3 | $2.09M | Buy |
35,619
+16,519
| +86% | +$970K | ﹤0.01% | 2052 |
|
|
2021
Q2 | $926K | Buy |
19,100
+12,302
| +181% | +$596K | ﹤0.01% | 2805 |
|
|
2021
Q1 | $264K | Sell |
6,798
-612
| -8% | -$23.8K | ﹤0.01% | 3453 |
|
|
2020
Q4 | $460K | Buy |
+7,410
| New | +$460K | ﹤0.01% | 2942 |
|